Jefferies Raises Fortrea (FTRE) PT to $9.50 Amid Improved Biotech Funding

Fortrea Holdings Inc. (NASDAQ:FTRE) is one of the best IPO stocks to buy and hold for 3 years. On September 9, Jefferies raised the firm’s price target on Fortrea to $9.50 from $7, while keeping a Hold rating on the shares. This sentiment was mainly driven by the biotech funding being stronger in the last 3 months, and bookings improving across the contract research organization industry. Earlier, for the second quarter of 2025, Fortrea Holdings reported a revenue of $710.3 million, which was an increase ...